Menu
Model Image 10

Frequently asked questions

We understand you will have questions. Many common queries are below, if you have more questions feel free to use our clinic finder to locate a specialist near you.

Model is not an actual patient.

How long does a treatment take?

A treatment takes approximately 30 minutes, depending on the areas treated.

When will I see the effects of the treatment?

Volumising effects and a reduction in wrinkles and folds can be seen immediately after treatment. ELLANSÉ will then gradually stimulate the production of your body’s own collagen to treat the underlying causes of facial ageing for long- lasting and natural-looking results.

How long will the results last?

Natural-looking and immediate results will last from 18 months up to 3 years*, depending on which ELLANSÉ option your physician recommends for you.

The results are maintained for the expected duration of effect according to the Ellansé option chosen, enabling you to avoid multiple sessions.

*Expected longevity in-vivo based on extrapolation of clinical data from Ellansé-S, Ellansé-M and accepted PCL degradation behaviour.

Is the procedure painful?

Tiny amounts of ELLANSÉ are injected into the skin using an ultrafine needle, so any discomfort is minimal. It’s quick, simple, virtually painless, and gives instant results.

What is ELLANSÉ made up of?

ELLANSÉ is composed of unique Polycaprolactone (PCL) microspheres and Carboxymethyl Cellulose (CMC) carrier gel, all naturally broken down by the body into carbon dioxide and water and then eliminated without leaving any traces in your body.

How many sessions are generally needed?

With ELLANSÉ, only one session is needed for immediate results and long-lasting correction, making ELLANSÉ a cost-effective treatment that gives excellent value for money.

Is it OK to combine ELLANSÉ with other aesthetic treatments?

ELLANSÉ should not be used in (or close to) sites where previous skin augmentation procedures have been applied. Please speak to your physician for more information.

What should I do following treatment?

The patient should be informed that he or she should minimize exposure of the treated area to excessive sun and UV lamp exposure and extreme cold weather until any initial swelling and redness has resolved.

Are there any side effects?

Like all procedures of this type there is a possibility of adverse events, although not everybody experiences them. These adverse events include but are not limited to infection, minimal acute inflammatory tissue reaction (redness, swelling, rash, oedema, erythema, lumps/nodules etc.), pain (which may be temporary or persistent in nature), transient haematoma or bruising. For a full list consult Instructions for Use.

Amanda Clinic2 Min

Speak to a professional

Use our clinic finder to talk to an ELLANSÉ physician.

FIND A CLINIC

INDICATION:

The EU approved intended use is: Ellansé (a Poly-ɛ-caprolactone-based dermal filler) is an injectable implant, indicated for subdermal implantation in the face for the lasting correction of wrinkles and facial aging signs or conditions.

INDICATION:

The EU approved intended use is: Ellansé (a Poly-ɛ-caprolactone-based dermal filler) is an injectable implant, indicated for subdermal implantation in the face for the lasting correction of wrinkles and facial aging signs or conditions.

Important Safety Considerations:

Like all procedures of this type there is a possibility of adverse events, although not everybody experiences them. These adverse events include but are not limited to infection, minimal acute inflammatory tissue reaction (redness, swelling, rash, oedema, erythema, lumps/nodules etc.), pain (which may be temporary or persistent in nature), transient haematoma or bruising.

Other potential adverse events include

- Injection related reactions, include itching, discoloration or tenderness may occur at the site of the injection. These usually resolve spontaneously within several days after the injection.

- As with any implant material possible adverse reactions that may occur include, but are not limited to the following: hypersensitivity, allergic reactions, inflammation, infection, fistula formation, haematoma, seroma, extrusion, induration formation, inadequate healing, skin discoloration, oedema, contusions/bruises, ecchymosis, inadequate or excessive augmentation, loss of correction, interference with local circulation if injected into a blood vessel resulting in vessel laceration, occlusion, embolism, infarction, and abscess at implant site which may result in induration and/or scar formation.

- Rare but serious adverse events associated with the intravascular injection of soft tissue fillers in the face have been reported and include temporary or permanent vision impairment, blindness, cerebral ischemia or cerebral hemorrhage, leading to stroke, skin necrosis, damage to underlying facial structures, nausea and vomiting, lack of ocular movement, significant skin changes, ptosis, exotropia and neurological complications.

- Adverse events, other than mentioned above, could occur as can be with any medical intervention.

All (potential) adverse side effects and incidents should be reported immediately to the Sinclair Pharma Corporate Safety Group: quality@sinclairpharma.com